Zealand

ZEAL NASDAQ
21.04
-0.11
-0.53%
Opening 15:07 08/19 EDT
Open
20.74
Prev Close
21.15
High
21.04
Low
20.74
Volume
1.38K
Avg Vol (3M)
13.26K
52 Week High
23.55
52 Week Low
11.51
% Turnover
0.00%
Market Cap
668.03M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Zealand ZEAL stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Zealand Pharma A/S is a Denmark-based biopharmaceutical company engaged in the discovery, development and commercialization of peptide-based medicines. The Company's pipeline comprises two implementation areas: Cardio-metabolic diseases and Other indications. The Cardio-metabolic diseases area includes medicines for diabetes and obesity treatment, such as Lyxumia (Lixisenatide), Lyxumia/Lantus, ZP2929 and Danegaptide. The Other indications area offers ZP1848, Elsiglutide and ZP1480 (ABT-719) drugs for inflammatory bowel disease, chemotherapy-induced diarrhea and acute kidney injury treatment. Furthermore, the Company collaborates with a number of partners, such as Sanofi, Helsinn, Boehringer Ingelheim, Abbvie and Eli Lilly.
MORE >

Recently

Name
Price
%Change